Use of Oral Probiotics to Reduce Urinary Oxalate Excretion

NCT00587041 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Nephrolithiasis
Hyperoxaluria
Crohn's Disease

Interventions

DIETARY_SUPPLEMENT: Oxadrop
DIETARY_SUPPLEMENT: Agri-King Synbiotic (AKSB)
OTHER: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]